Observed mortality at 6 months for patients with COPD and non-COPD patients stratified by different versions of the GRACE score predicted risk of death
| Normal GRACE score | ||
|---|---|---|
| GRACE score predicted risk level | Observed mortality—non-COPD (%) | Observed mortality—COPD (%) |
| Low (<3%) | 1.0 | 1.9 |
| Med (3%–6%) | 3.1 | 5.8 |
| High (>6%) | 18.4 | 23.3 |
| Normal GRACE score×1.3 for patients with COPD | ||
| GRACE score predicted risk level | Observed mortality—non-COPD (%) | Observed mortality—COPD (%) |
| Low (<3%) | 1.0 | 1.3 |
| Med (3%–6%) | 3.1 | 3.8 |
| High (>6%) | 18.4 | 21.4 |
| MINAP-derived GRACE score | ||
| GRACE score predicted risk level | Non-observed mortality—non-COPD (%) | Observed mortality—COPD (%) |
| Low (<3%) | 1.1 | 1.1 |
| Med (3%–6%) | 3.4 | 6.0 |
| High (>6%) | 20.6 | 25.2 |
| MINAP-derived GRACE score and COPD | ||
| GRACE score predicted risk level | Observed mortality—non-COPD (%) | Observed mortality—COPD (%) |
| Low (<3%) | 1.1 | 1.4 |
| Med (3%–6%) | 3.7 | 4 |
| High (>6%) | 21.0 | 23.3 |
COPD, chronic obstructive pulmonary disease; GRACE, Global Registry of Acute Coronary Events; MINAP, Myocardial Ischaemia National Audit Project.